SD
Shasikanta Das
About Shasikanta Das
Data last updated:
Shasikanta Das is a Managing Director at Rezyrc Life Science Private Limited (since 2018), Managing Director at Cryzer Formulation Private Limited (since 2016) and Director at Cryzer Pharma Private Limited (since 2016). The companies operate in Healthcare and Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rezyrc Life Science Private Limited U74999OR2018PTC029043 | Managing Director | 18 Jun 2018 | 2018 | Active | |
| Cryzer Formulation Private Limited U24299OR2016PTC026093 | Managing Director | 05 Dec 2016 | 2016 | Active | |
| Cryzer Pharma Private Limited U74999JH2016PTC008971 | Director | 13 Jul 2016 | 2016 | Active |
Board colleagues of Shasikanta Das
| Name | DIN | Company | Designation |
|---|---|---|---|
| Diptimayee Das | 07644936 | Rezyrc Life Science Private Limited , Cryzer Formulation Private Limited | Director |
| Nawaljit Singh Gandhi | 07529274 | Cryzer Pharma Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shasikanta Das
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shasikanta Das
Shasikanta Das currently holds 3 directorships: Rezyrc Life Science Private Limited (Managing Director, since 18 Jun 2018); Cryzer Formulation Private Limited (Managing Director, since 05 Dec 2016); Cryzer Pharma Private Limited (Director, since 13 Jul 2016).
Shasikanta Das was first appointed on 13 Jul 2016 as Director at Cryzer Pharma Private Limited. The most recent appointment on record is 18 Jun 2018 at Rezyrc Life Science Private Limited.
The current boards of Shasikanta Das's companies include Diptimayee Das (Rezyrc Life Science Private Limited), Nawaljit Singh Gandhi (Cryzer Pharma Private Limited).